Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethidine).
D000109:Acetylcholine / Q000494:pharmacology; D000284:Administration, Oral; D000818:Animals; D001237:Asphyxia / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects*; D002490:Central Nervous System / Q000187:drug effects*; D004594:Electrophysiology; D005260:Female; D006145:Guanethidine / Q000008:administration & dosage / Q000494:pharmacology*; D006830:Hydralazine / Q000008:administration & dosage / Q000494:pharmacology*; D006977:Hypertension, Renal / Q000139:chemically induced; D008750:Methyldopa / Q000008:administration & dosage / Q000494:pharmacology*; D009409:Nerve Crush; D009474:Neurons / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology
D006830:Hydralazine; D008750:Methyldopa; D000109:Acetylcholine; D009638:Norepinephrine; D006145:Guanethidine